Survey of ophthalmology最新文献_第6页

Dynamic procedures for eyelid involvement in facial nerve palsy 面神经麻痹中眼睑受累的动态治疗。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-13 DOI: 10.1016/j.survophthal.2025.03.002

Anthony Yao , Ahsen Hussain , Ruben Kannan , Charles Nduka , Raman Malhotra

引用次数: 0

From anatomical and functional observations to molecular dynamics in internal limiting membrane peeling 从解剖和功能观察到内限制膜剥离的分子动力学。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-13 DOI: 10.1016/j.survophthal.2025.02.008

Axel Petzold

引用次数: 0

Oral fluorescein angiography in pediatric ophthalmology 口腔荧光素血管造影在儿童眼科中的应用。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-13 DOI: 10.1016/j.survophthal.2025.03.005

Ramsey Ghaleb BA , Ahmed B. Sallam MD, PhD , Florin Grigorian MD , Paul H. Phillips MD , Abdelrahman M. Elhusseiny MD, MSc

{"title":"Oral fluorescein angiography in pediatric ophthalmology","authors":"Ramsey Ghaleb BA , Ahmed B. Sallam MD, PhD , Florin Grigorian MD , Paul H. Phillips MD , Abdelrahman M. Elhusseiny MD, MSc","doi":"10.1016/j.survophthal.2025.03.005","DOIUrl":"10.1016/j.survophthal.2025.03.005","url":null,"abstract":"<div><div>We evaluate the administration protocols, diagnostic utility, and safety of oral fluorescein angiography (OFA) in pediatric ophthalmological diseases, with a secondary objective of comparing OFA to intravenous fluorescein angiography (IVFA) in terms of image quality and clinical utility. A comprehensive search of PubMed, Embase, and Web of Science was conducted, focusing on studies involving pediatric patients. Fifteen studies were included, with 11 assessing the utility and safety of OFA and 4 comparing it to IVFA. These studies covered 581 eyes from 464 patients. The most common dosing protocol for OFA involved 25 mg/kg of 10 % fluorescein dye, with various dilution solutions and fasting requirements enhancing image quality. Adverse effects were minimal, with mild reactions such as itching or nausea observed in 0.019 % of patients. OFA demonstrated good diagnostic value across various pathologies, including retinal vasculopathies, uveitis, disc edema, and Coats disease. OFA is a feasible imaging modality that is a less invasive and better-tolerated alternative to IVFA in the pediatric population, providing high-quality diagnostic images with fewer adverse effects. Our review highlights the need for standardized administration protocols and further research into optimizing dosing and ingestion techniques to enhance image quality and diagnostic utility.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 5","pages":"Pages 849-858"},"PeriodicalIF":5.1,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The role of retinal pigment epithelial senescence and the potential of senotherapeutics in age-related macular degeneration 视网膜色素上皮衰老的作用和衰老治疗药物在年龄相关性黄斑变性中的潜力。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-13 DOI: 10.1016/j.survophthal.2025.03.004

Yingying Chen MD, Feipeng Jiang, Yue Zeng MD, Meixia Zhang MD

引用次数: 0

The etiologic and pathogenic spectrum of exposure keratopathy: Diagnostic and therapeutic implications 暴露性角膜病的病因和致病范围：诊断和治疗意义。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-09 DOI: 10.1016/j.survophthal.2025.03.001

Alejandro Rodriguez-Garcia MD , Raul E. Ruiz-Lozano MD , Raul H. Barcelo-Canton MD , Hector M. Marines-Sanchez MD , J. Homar Paez-Garza MD

{"title":"The etiologic and pathogenic spectrum of exposure keratopathy: Diagnostic and therapeutic implications","authors":"Alejandro Rodriguez-Garcia MD , Raul E. Ruiz-Lozano MD , Raul H. Barcelo-Canton MD , Hector M. Marines-Sanchez MD , J. Homar Paez-Garza MD","doi":"10.1016/j.survophthal.2025.03.001","DOIUrl":"10.1016/j.survophthal.2025.03.001","url":null,"abstract":"<div><div>Exposure keratopathy (EK) is an underestimated ocular surface disorder that involves multiple underlying pathophysiologic mechanisms. It results from an exposed cornea due to different causes of eyelid insufficiency or blinking dysfunction, ocular globe protrusion, a negative orbital vector, and diverse contributing factors leading to impaired ocular surface homeostasis and the potential for vision loss. EK can be congenital, acquired, or induced, and various risk factors predispose patients to corneal exposure. These causes can be grouped into those related to proptosis and eyelid malformations, malfunctioning, or acquired deformity.</div><div>If detected early, EK offers a range of effective treatment options. The superficial punctate keratitis and dryness of the cornea's lower third can be successfully treated at the initial stages; however, if left untreated, EK can progress to extensive epithelial erosion, persistent epithelial defects, stromal melting, vascularization, squamous metaplasia, and opportunistic infections, leading to significant visual loss. Different and varied treatment modalities, including medical and surgical, are available for patients with EK, depending on the disease stage, the underlying mechanism, and the cause.</div><div>We examine the risk factors, causes, and range of pathologies associated with EK. Exploring the mechanisms that contribute to the development of the disorder's clinical manifestations provides valuable insights that can help clinicians detect and diagnose the disease promptly and plan appropriate targeted treatments.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 5","pages":"Pages 882-899"},"PeriodicalIF":5.1,"publicationDate":"2025-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143596866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Response to Letter to the Editor by Professor Axel Petzold 对Axel Petzold教授给编辑的信的回应。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-06 DOI: 10.1016/j.survophthal.2025.02.007

Elham Sadeghi, Jay Chhablani

引用次数: 0

Ocular manifestations secondary to cocaine abuse 可卡因滥用后的眼部表现——综述：可卡因滥用的眼部并发症。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-05 DOI: 10.1016/j.survophthal.2025.02.004

Kaersti L. Rickels , Ramsey Ghaleb , Abdelrahman M. Elhusseiny , Muhammad Z. Chauhan , Joseph Toma , Tony Wang , Daniel Cheng , Asim Ali , Ahmed B. Sallam

{"title":"Ocular manifestations secondary to cocaine abuse","authors":"Kaersti L. Rickels , Ramsey Ghaleb , Abdelrahman M. Elhusseiny , Muhammad Z. Chauhan , Joseph Toma , Tony Wang , Daniel Cheng , Asim Ali , Ahmed B. Sallam","doi":"10.1016/j.survophthal.2025.02.004","DOIUrl":"10.1016/j.survophthal.2025.02.004","url":null,"abstract":"<div><div>Cocaine, a prevalent drug of abuse, is associated with numerous systemic health complications, including significant ocular manifestations. These ocular effects range from mild to severe, with the potential for irreversible vision loss. Despite the extensive documentation of cocaine's systemic effects, the literature still lacks a focused review of its ocular manifestations. We methodically explore the epidemiology, pathophysiology, clinical presentations, diagnostic challenges, and therapeutic approaches related to cocaine-associated ocular manifestations. By categorizing the findings based on the anatomical location and type of pathology—orbital, corneal, retinal, neuro-ophthalmic, glaucoma-related, and uveal manifestations—we aim to provide a detailed overview that aids in early diagnosis and effective management of ocular disease secondary to cocaine use. Our review highlights the importance of awareness among clinicians, showcasing the wide range of ocular pathology to improve patient outcomes and prevent long-term ocular damage after cocaine abuse.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 4","pages":"Pages 825-832"},"PeriodicalIF":5.1,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Pharmacological agents for treatment of proliferative vitreoretinopathy: A systematic review and network meta-analysis 治疗增生性玻璃体视网膜病变的药物：一项系统综述和网络荟萃分析。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-01 DOI: 10.1016/j.survophthal.2025.02.005

Sina Khosravi Mirzaei MD , Firouze Hatami MD , Sare Safi PhD , Zahra Khorrami PhD , Fatemeh Khosravi Shadmani PhD , Seyed Mohamadmehdi Moshtaghion MD , Hamid Ahmadieh MD

{"title":"Pharmacological agents for treatment of proliferative vitreoretinopathy: A systematic review and network meta-analysis","authors":"Sina Khosravi Mirzaei MD , Firouze Hatami MD , Sare Safi PhD , Zahra Khorrami PhD , Fatemeh Khosravi Shadmani PhD , Seyed Mohamadmehdi Moshtaghion MD , Hamid Ahmadieh MD","doi":"10.1016/j.survophthal.2025.02.005","DOIUrl":"10.1016/j.survophthal.2025.02.005","url":null,"abstract":"<div><div>We performed a comprehensive systematic review and network meta-analysis (NMA) to assess the efficacy of pharmacological agents for the treatment of proliferative vitreoretinopathy (PVR) following retinal detachment (RD) surgery. A systematic search was performed across PubMed, Scopus, Web of Science, and Embase. Randomized and non-randomized controlled trials and comparative observational studies evaluating the effect of pharmacological agents in a clinical setting were included. The primary outcome was retinal reattachment rate, and secondary outcomes were PVR recurrence, reoperation, intraocular pressure (IOP), epiretinal membrane (ERM), and macular edema. A total of 23 studies with 1749 eyes were included. Twelve different drugs or drug combinations were assessed. The NMA was performed for retinal reattachment, PVR recurrence, and reoperation rate outcomes. Among the pharmacological agents analyzed, adjunctive therapy with 13-cis-retinoic acid (13-cis-RA) demonstrated a statistically significant improvement in retinal reattachment rates (RR=1.36, 95 % CI: 1–1.84) and a reduction in reoperation rates (RR=0.23, 95 % CI: 0.07–0.69) compared to the control group, while none of the other drugs had statistically significant results. Additionally, adjunctive therapy did not yield significant improvements in IOP, ERM, or macular edema, except for a reduction in macular edema associated with dexamethasone in one study. This systematic review and NMA indicate that most pharmacological agents could not significantly improve retinal reattachment, reduce PVR recurrence, or lower reoperation rates following RD surgery. 13-cis-RA was the only drug that showed a significant impact on lowering retinal detachment and reoperation rates. Further high-quality clinical trials are warranted to confirm these findings.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"70 4","pages":"Pages 633-644"},"PeriodicalIF":5.1,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143543131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Advancing ophthalmology with large language models: Applications, challenges, and future directions 用大语言模型推进眼科：应用、挑战和未来方向。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-03-01 DOI: 10.1016/j.survophthal.2025.02.009

Qi Zhang , Shaopan Wang , Xu Wang , Changsheng Xu , Jiajun Liang , Zuguo Liu

引用次数: 0

The mirrored arterial dilemma 镜像动脉困境。

IF 5.1 2区医学

Survey of ophthalmology Pub Date : 2025-02-28 DOI: 10.1016/j.survophthal.2025.02.006

Skenda Jean-Charles , Marissa K. Shoji , Don O. Kikkawa , M. Tariq Bhatti

引用次数: 0